-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LTM/XsaqlK6ZULXUGfJS2hnJWENZMtKR8ztyMYmSLg+XymxzGomafb6FPJcwd36g Ovq8SA0X+5spM6fc7odCEg== 0001299933-08-003745.txt : 20080805 0001299933-08-003745.hdr.sgml : 20080805 20080805141305 ACCESSION NUMBER: 0001299933-08-003745 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080805 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20080805 DATE AS OF CHANGE: 20080805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TLC VISION CORP CENTRAL INDEX KEY: 0001010610 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 980151150 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29302 FILM NUMBER: 08990751 BUSINESS ADDRESS: STREET 1: 5280 SOLAR DRIVE STREET 2: SUITE 100 CITY: MISSISSAUGA ONTARIO STATE: A6 ZIP: 00000 BUSINESS PHONE: 636-534-2300 MAIL ADDRESS: STREET 1: 16305 SWINGLEY RIDGE ROAD STREET 2: SUITE 300 CITY: CHESTERFIELD STATE: MO ZIP: 63017 FORMER COMPANY: FORMER CONFORMED NAME: TLC LASER CENTER INC DATE OF NAME CHANGE: 19960314 8-K 1 htm_28388.htm LIVE FILING TLC Vision Corporation (Form: 8-K)  

 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   August 5, 2008

TLC Vision Corporation
__________________________________________
(Exact name of registrant as specified in its charter)

     
New Brunswick 0-29302 980151150
_____________________
(State or other jurisdiction
_____________
(Commission
______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
5280 Solar Drive, Suite 100, Mississauga, Ontario   L4W 5M8
_________________________________
(Address of principal executive offices)
  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   (905) 602-2020

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 2.02 Results of Operations and Financial Condition.

On August 5, 2008, TLC Vision Corporation issued a press release announcing its financial results for the second quarter ending June 30, 2008. A copy of the press release is attached hereto and incorporated herein as Exhibit 99.1.

This Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.





Item 9.01 Financial Statements and Exhibits.

Exhibit 99.1, August 5, 2008 Press Release & Financials.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    TLC Vision Corporation
          
August 5, 2008   By:   /s/ Brian L. Andrew
       
        Name: Brian L. Andrew
        Title: General Counsel


Exhibit Index


     
Exhibit No.   Description

 
99.1
  August 5, 2008 Press Release
EX-99.1 2 exhibit1.htm EX-99.1 EX-99.1
     
News Release
  Contact:
For Immediate Release
  James J. Hyland, VP Investor Relations
(636) 534-2369
Email: investor.relations@tlcvision.com

TLCVision Reports Second Quarter 2008 Results

ST. LOUIS, MO, August 5, 2008: TLCVision Corporation (NASDAQ:TLCV; TSX:TLC), North America’s premier eye care services company, today reported second quarter earnings for the quarter ended June 30, 2008.

Jim Wachtman, President and Chief Executive Officer of TLCVision, commented, “Our results this quarter in our Lasik businesses were significantly impacted by the weak economy, as evidenced by a consumer confidence index that has declined to a level not seen since the early 1990’s.

In the first quarter, we recorded strong growth in all three of our refractive center patient acquisition channels, and posted record results. In the second quarter, however, we experienced a significant weakening in procedure volume, although our performance was ahead of the overall industry that experienced a decline estimated at 25% to 30%. We continue to gain market share despite lower volumes, with our same-store, majority-owned centers posting a 6.2% procedure decline through the first half of 2008 compared to an industry that is estimated to have declined 20% during the same six month period.

It is also important to remember that approximately 30% of our business volume is in non-discretionary sectors which are less susceptible to economic pressures. Those businesses continue to show solid growth. We continue to remain focused on managing costs, paying down debt and delivering the best clinical care in the industry.”

Second Quarter 2008 Results

    Revenue for the second quarter was $74.1 million, compared to $80.1 million for the prior year period, a decrease of 7.5%

    Refractive Centers revenue was $39.1 million, down 16.9% due to a shortfall in same-store, majority-owned center procedures, which totaled 21,333 in the second quarter, a 22.8% decrease from the prior year period. Average revenue per center procedure increased to $1,726, up 4% from the prior year period.

    Doctor Services revenue increased 2.7% to $25.5 million on the strength of higher surgical and product unit volumes.

    Eye Care revenue increased 15.8% to $9.5 million as a result of increased franchises and revenue per franchisee.

    Consolidated net loss for the second quarter was ($2.2) million, compared to net income of $0.9 million for the prior year period. Loss per diluted share for the second quarter was ($0.04), compared to earnings per diluted share of $0.01 for the prior year period.

    Operating cash flow for the quarter ended June 30, 2008, was ($0.3) million, reflecting a reversal of working capital benefits from the first quarter of 2008.

    Total debt was reduced during the second quarter by $1.1 million.

Six Month 2008 Results

    Revenue for the six months ended June 30, 2008 was $164.5 million, compared to $162.4 million for the prior year period, an increase of 1.2%.

    Refractive Centers revenue was $98.0 million, a decrease of $0.8 million from the prior year period. Same-store, majority-owned center procedures totaled 54,109, a decrease of 6.2%. Average revenue per center procedure increased to $1,713, up 4% from the prior year period.

    Doctor Services revenue increased 1.5% to $50.6 million.

    Eye Care revenue increased 14.9% to $15.8 million.

    Consolidated income for the six months ended June 30, 2008, was $3.9 million, compared to $4.4 million for the prior year period. Earnings per diluted share for the first six months were $0.08 compared to $0.06 for the prior year period.

    Operating cash flow for the six months ended June 30, 2008, was $22.5 million, or $0.45 per diluted share, compared to $21.7 million, or $0.31 per diluted share, in the prior year period, up 45% on a per diluted share basis.

    Total debt was reduced during the first six months of 2008 by $7.9 million, or 7.2%.

Second Quarter 2008 Earnings Call

TLCVision invites all interested parties to participate in a conference call during which time the financial and operating results will be discussed. The company will host a conference call and live webcast with investors and analysts on Tuesday, August 5, 2008 at 9:00 am (EDT). To access, please dial 866-303-7746 or 416-641-6141 (international callers). The call will be broadcast live on the company’s web site at www.tlcv.com under the “Webcasts” link in the Investor Relations section.

A replay of the conference call will be available until August 19, 2008. To access the replay, dial 800-408-3053 or 416-695-5800 (international callers) and enter the pass code: 3266437. The call will also be archived on the company’s web site at www.tlcv.com under the “Webcasts” link in the Investor Relations section.

Forward Looking Statements

This press release contains certain forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934, which statements can be identified by the use of forward looking terminology, such as “may”, “will”, “expect”, ”intend”, “anticipate”, “estimate”, “predict”, “plans” or “continue” or the negative thereof or other variations thereon or comparable terminology referring to future events or results. The Company’s actual results could differ materially from those anticipated in these forward looking statements as a result of numerous factors, including the timing of expenditures, effects of competition, changes to pricing, acquisitions and expansion opportunities, any of which could cause actual results to vary materially from current results or TLCVision’s anticipated future results. See the Company’s reports filed with the Canadian Securities Regulators and the U.S. Securities and Exchange Commission from time to time for cautionary statements identifying important factors with respect to such forward looking statements, including certain risks and uncertainties, that could cause actual results to differ materially from results referred to in forward looking statements. TLCVision assumes no obligation to update the information contained in this press release.

About TLCVision

TLCVision is North America’s premier eye care services company, providing eye doctors with the tools and technologies needed to deliver high-quality patient care. Through its centers’ management, technology access service models, extensive optometric relationships, direct to consumer advertising and managed care contracting strength, TLCVision maintains leading positions in Refractive, Cataract and Eye Care markets. Information about vision correction surgery can be found on the TLC Laser Eye Centers’ website at www.lasik.com. More information about TLCVision can be found on the Company’s website at www.tlcv.com.

1

                                                                                 
TLC VISION CORPORATION
                                                                               
CONSOLIDATING STATEMENTS OF OPERATIONS (UNAUDITED)
                                                                               
(In thousands, except per share amounts)
                                                                               
    Three Months Ended June 30, 2008                   Three Months Ended June 30, 2007                
                 
 
  Results Before AMD                           Results Before AMD                                
 
  Segment   AMD Segment   Total TLCVision           Segment           AMD Segment   Total TLCVision
                                             
Revenues:
                                                                               
Refractive centers
  $ 39,057     $     $ 39,057                     $ 47,006             $             $ 47,006  
Doctor services     25,528       -       25,528             24,861     -                       24,861  
Eye care     9,512       -       9,512             8,214     -                       8,214  
                                             
Total revenues     74,097       -       74,097             80,081     -                       80,081  
 
                                                                               
Cost of revenues (excluding amortization):
                                                                               
Refractive centers     29,409       -       29,409             32,705     -                       32,705  
Doctor services     18,680       -       18,680             17,659     -                       17,659  
Eye care     4,691       -       4,691             3,959     -                       3,959  
                                             
Total cost of revenues (excluding
                                                                               
amortization)     52,780       -       52,780             54,323     -                       54,323  
                                             
 
                                                                               
Gross profit     21,317       -       21,317             25,758     -                       25,758  
                                             
 
                                                                               
General and administrative     6,986       -       6,986             8,940     -                       8,940  
Marketing and sales     10,209       -       10,209             10,686     -                       10,686  
Amortization of intangibles     803       -       803             918     -                       918  
Other (income) expense, net
    (359 )           (359 )             96                                     96  
                                                                     
Total operating expenses     17,639       -       17,639             20,640     -                       20,640  
                                             
Operating income     3,678       -       3,678             5,118     -                       5,118  
 
                                                                               
Gain on sale of OccuLogix, Inc.
                                                                               
stock     -       -       -               -             933             933  
Interest income     216       -       216             579     -                       579  
Interest expense     (2,414 )     -       (2,414 )           (689)     -                       (689 )
Minority interest expense     (3,076 )     -       (3,076 )           (2,643)     -                       (2,643 )
(Loss) earnings from equity
                                                                               
investments     (319 )     -       (319 )           499   (1,614)             (1,115 )
                                             
(Loss) income from continuing
                                                                               
operations before income taxes     (1,915 )     -       (1,915 )           2,864   (681)             2,183  
Income tax expense     (285 )     -       (285 )           (1,653)     -                       (1,653 )
                                             
(Loss) income from continuing
                                                                               
operations     (2,200 )     -       (2,200 )           1,211   (681)             530  
Income from discontinued
                                                                               
operations, net of tax     -       -       -             346     -                       346  
                      -                      
 
                                                                               
Net (loss) income
  $ (2,200 )   $     $ (2,200 )                   $ 1,557             $ (681 )           $ 876  
                                             
 
                                                                               
(Loss) earnings per share — diluted
  $ (0.04 )   $     $ (0.04 )                   $ 0.02             $ (0.01 )           $ 0.01  
                                             
 
                                                                               
Weighted average number of common
                                                                               
shares outstanding — diluted     50,292       50,292       50,292             68,581   68,581             68,581  
Note: The AMD segment includes the Company’s interest in OccuLogix, Inc.
                                                                               
TLC VISION CORPORATION
                                                                               
CONSOLIDATING STATEMENTS OF OPERATIONS (UNAUDITED)
                                                                               
(In thousands, except per share amounts)
                                                                               
    Six Months Ended June 30, 2008                   Six Months Ended June 30, 2007                
                 
 
  Results Before AMD                           Results Before AMD                                
 
  Segment   AMD Segment   Total TLCVision           Segment           AMD Segment   Total TLCVision
                                             
Revenues:
                                                                               
Refractive centers
  $ 98,024     $     $ 98,024                     $ 98,790             $             $ 98,790  
Doctor services     50,591       -       50,591             49,851     -                       49,851  
Eye care     15,837       -       15,837             13,786     -                       13,786  
                                             
Total revenues     164,452       -       164,452             162,427     -                       162,427  
 
                                                                               
Cost of revenues (excluding amortization):
                                                                               
Refractive centers     66,766       -       66,766             66,941     -                       66,941  
Doctor services     36,821       -       36,821             35,460     -                       35,460  
Eye care     7,513       -       7,513             6,434     -                       6,434  
                                             
Total cost of revenues (excluding
                                                                               
amortization)     111,100       -       111,100             108,835     -                       108,835  
                                             
 
                                                                               
Gross profit     53,352       -       53,352             53,592     -                       53,592  
                                             
 
                                                                               
General and administrative     15,353       -       15,353             18,857     -                       18,857  
Marketing and sales     21,860       -       21,860             19,121     -                       19,121  
Amortization of intangibles     1,633       -       1,633             1,702     -                       1,702  
Other (income) expense, net     (556 )     -       (556 )           534     -                       534  
                                                                     
Total operating expense     38,290       -       38,290             40,214     -                       40,214  
                                             
Operating income     15,062       -       15,062             13,378     -                       13,378  
 
                                                                               
Gain on sale of OccuLogix, Inc.
                                                                               
stock     -       -       -               -             933             933  
Interest income     426       -       426             1,147     -                       1,147  
Interest expense     (4,890 )     -       (4,890 )           (1,129)     -                       (1,129 )
Minority interest expense     (5,892 )     -       (5,892 )           (5,091)     -                       (5,091 )
(Loss) earnings from equity
                                                                               
investments     (102 )     -       (102 )           1,310   (4,131)             (2,821 )
                                             
Income (loss) from continuing
                                                                               
operations before income taxes     4,604       -       4,604             9,615   (3,198)             6,417  
Income tax expense     (732 )     -       (732 )           (2,604)     -                       (2,604 )
                                             
Income (loss) from continuing
                                                                               
operations     3,872       -       3,872             7,011   (3,198)             3,813  
Income from discontinued
                                                                               
operations, net of tax     -       -       -             541     -                       541  
                      -                      
 
                                                                               
Net income (loss)
  $ 3,872     $     $ 3,872                     $ 7,552             $ (3,198 )           $ 4,354  
                                             
 
                                                                               
Earnings (loss) per share — diluted
  $ 0.08     $     $ 0.08                     $ 0.11             $ (0.05 )           $ 0.06  
                                             
 
                                                                               
Weighted average number of common
                                                                               
shares outstanding — diluted     50,293       50,293       50,293             69,104   69,104             69,104  
 
                                                                               
Note: The AMD segment includes the Company’s interest in OccuLogix, Inc.
                                                                               
TLC VISION CORPORATION
                                                                               
CONSOLIDATING BALANCE SHEETS
                                                                               
(In thousands)
                                                                               
 
          June 30, 2008                                   December 31, 2007                
                      -                                  
 
  Results Before AMD                           Results Before AMD                                
 
  Segment   AMD Segment   Total TLCVision           Segment (Unaudited)   AMD Segment (Unaudited)   Total TLCVision
                                             
ASSETS
                                                                               
Current assets
                                                                               
Cash and cash equivalents
  $ 14,061     $     $ 14,061                     $ 12,925             $             $ 12,925  
Accounts receivable, net     18,655       -       18,655             18,076     -                       18,076  
Prepaid expenses, inventory and
                                                                               
other     14,771       -       14,771             14,882     -                       14,882  
                                             
Total current assets     47,487       -       47,487             45,883     -                       45,883  
 
                                                                               
Restricted cash     208       -       208             1,101     -                       1,101  
Investments and other assets     17,711       -       17,711             17,524     -                       17,524  
Goodwill     101,895       -       101,895             94,346     -                       94,346  
Other intangible assets, net     15,474       -       15,474             17,020     -                       17,020  
Fixed assets, net     57,505       -       57,505             61,936     -                       61,936  
                                                                     
Total assets
  $ 240,280     $     $ 240,280                     $ 237,810             $             $ 237,810  
                                             
 
                                                                               
LIABILITIES
                                                                               
Current liabilities
                                                                               
Accounts payable
  $ 23,427     $     $ 23,427                     $ 17,177             $             $ 17,177  
Accrued liabilities     22,270       -       22,270             28,115     -                       28,115  
Current maturities of long-term debt     7,716       -       7,716             11,732     -                       11,732  
                                             
Total current liabilities     53,413       -       53,413             57,024     -                       57,024  
 
                                                                               
Long-term debt, less current
                                                                               
maturities     94,524       -       94,524             98,417     -                       98,417  
Other long-term liabilities     9,878       -       9,878             5,023     -                       5,023  
Minority interests     15,941       -       15,941             15,224     -                       15,224  
                                             
Total liabilities     173,756       -       173,756             175,688     -                       175,688  
                                             
 
                                                                               
STOCKHOLDERS’ EQUITY
                                                                               
Common stock     310,049       28,501       338,550             308,972   28,501             337,473  
Option and warrant equity     745       -       745             837     -                       837  
Other comprehensive income     (1,239 )     -       (1,239 )           (784)     -                       (784 )
Accumulated deficit     (243,031 )     (28,501 )     (271,532 )           (246,903)   (28,501)   (275,404)
                                                                     
Total stockholders’ equity     66,524       -       66,524             62,122     -                       62,122  
                                             
 
                                                                               
Total liabilities and stockholders’ equity
  $ 240,280     $     $ 240,280                     $ 237,810             $             $ 237,810  
                                             
 
                                                                               
Note: The AMD segment includes the Company’s interest in OccuLogix, Inc.
                                                                               
 
                                                                               
TLC VISION CORPORATION
                                                                               
CONSOLIDATING STATEMENTS OF CASH FLOWS (UNAUDITED)
                                                                               
(In thousands, except per share amounts)
                                                                               
    Six Months Ended June 30, 2008                   Six Months Ended June 30, 2007                
                 
 
  Results Before AMD                           Results Before AMD                                
 
  Segment   AMD Segment   Total TLCVision           Segment           AMD Segment   Total TLCVision
                                             
OPERATING ACTIVITIES
                                                                               
Net income (loss)
  $ 3,872     $     $ 3,872                     $ 7,552             $ (3,198 )           $ 4,354  
 
                                                                               
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
                                                                               
Depreciation and amortization     9,877       -       9,877             9,134     -                       9,134  
Deferred taxes     -       -       -             1,939     -                       1,939  
Minority interests     5,892       -       5,892             5,300     -                       5,300  
Loss from equity investments     102       -       102             (1,310)   4,131             2,821  
Gain on sales and disposals of
                                                                               
fixed assets     (289 )     -       (289 )           (81)     -                       (81 )
Gain on sale of Occulogix, Inc.
                                                                               
stock     -       -       -               -             (933)             (933 )
Gain on sale of businesses
    (145 )           (145 )                                                  
Non-cash compensation expense     711       -       711             731     -                       731  
Other     354       -       354             117     -                       117  
Changes in operating assets and liabilities, net of acquisitions
                                                                               
and dispositions:     2,173       -       2,173             (1,681)     -                       (1,681 )
                                             
Cash provided by operating
                                                                               
activities     22,547       -       22,547             21,701     -                       21,701  
                                             
 
                                                                           
INVESTING ACTIVITIES
                                                                           
Purchases of fixed assets     (1,957 )     -       (1,957 )           (7,281)     -                       (7,281 )
Proceeds from sales of fixed assets     550       -       550             268     -                       268  
Proceeds from sale of Occulogix,
                                                                               
Inc. stock, net     -       -       -             2,000     -                       2,000  
Distributions and loan payments
                                                                               
received from equity investments     945       -       945             1,857     -                       1,857  
Acquisitions and equity investments     (7,533 )     -       (7,533 )           (3,889)     -                       (3,889 )
Divestitures of business
    1,179             1,179                                                    
Proceeds from sales of short-term
                                                                               
investments     -       -       -             17,375     -                       17,375  
Purchases of short-term investments     -       -       -             (5,800)     -                       (5,800 )
Other
    (28 )           (28 )             33                                     33  
                                                         
Cash (used in) provided by
                                                                               
investing activities     (6,844 )     -       (6,844 )           4,563     -                       4,563  
                                             
 
                                                                           
FINANCING ACTIVITIES
                                                                           
Restricted cash movement
    893             893                                                    
Principal payments of debt
                                                                               
financing and capital leases     (17,411 )     -       (17,411 )           (3,497)     -                       (3,497 )
Proceeds from debt financing     7,385       -       7,385             85,317     -                       85,317  
Capitalized debt costs     (534 )     -       (534 )           (1,631)     -                       (1,631 )
Distributions to minority interests     (5,175 )     -       (5,175 )           (4,560)     -                       (4,560 )
Purchases of treasury stock     -       -       -             (115,748)     -             (115,748)
Proceeds from issuances of common
                                                                               
stock     275       -       275             2,154     -                       2,154  
                                                         
Cash used in financing activities     (14,567 )     -       (14,567 )           (37,965)     -                       (37,965 )
                                             
`
                                                                           
Net increase in cash and cash
                                                                               
equivalents during the period     1,136       -       1,136             (11,701)     -                       (11,701 )
Cash and cash equivalents,
                                                                               
beginning of period     12,925       -       12,925             28,917     -                       28,917  
                                             
Cash and cash equivalents, end of period
  $ 14,061     $     $ 14,061                     $ 17,216             $             $ 17,216  
                                             
 
                                                                               
Operating cash flow per diluted share
  $ 0.45     $     $ 0.45                     $ 0.31             $             $ 0.31  
 
                                                                               
Note: The AMD segment includes the Company’s interest in OccuLogix, Inc.
                                                                               

2 -----END PRIVACY-ENHANCED MESSAGE-----